FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074027610> ?p ?o ?g. }

• W2074027610 endingPage "2174" @default.
• W2074027610 startingPage "2170" @default.
• W2074027610 abstract "1 Measurement of plasma protein extravasation induced by the natural tachykinins following intradermal administration in rat skin indicated equipotency between substance P (SP), neurokinin A (NKA) and neurokinin B (NKB). The selective NK1 receptor agonist, [Sar9]SP sulphone was 10–100 times more potent than SP. The synthetic hexapeptide, septide, [pGlu6, Pro9]SP-(6–11), which has been proposed to act on a distinct NK1 receptor subtype/binding site was equipotent with [Sar9]SP sulphone. 2 The selective NK2 receptor agonist [βA1a8]NKA(4–10) (0.1-1 nmol) and the selective NK3 receptor agonist, senktide (0.1-1 nmol) were both ineffective in producing oedema. The selective NK2 receptor antagonist, SR 48, 968 (0.3 μmol kg−1) had no significant inhibitory effects upon oedema induced by approximately equiactive doses of SP (0.2 nmol), septide (0.002 nmol), [Sar9]SP sulphone (0.002 nmol), or NKB (0.3 nmol). These results together suggest that neither NK2 nor NK3 receptors are involved in oedema formation in rat skin. 3 The non-peptide tachykinin NK1 receptor antagonist, RP 67, 580 (1–3 μmol kg−1), inhibited plasma protein extravasation induced by septide (0.002 nmol) to a greater extent than that to SP (0.2 nmol). RP 67, 580 (1 μmol kg−1) produced a significant inhibition of approximately 66% of the response to septide (0.002 nmol) only. Increasing the dose of RP 67, 580 3 fold resulted in inhibition of the response to SP (0.2 nmol) and [Sar9]SP sulphone (0.002 nmol) by approximately 66% and 64% respectively with the response to septide being inhibited by approximately 70%. 4 Co-administration of the nitric oxide (NO) synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME) (0.1 μmol) with the relevant tachykinin, resulted in a significant attenuation of the oedema response to septide (0.1 nmol) producing only an approximate 56% inhibition of the response. The response to 0.2 nmol SP was unaffected whereas the response to a higher dose of 1 nmol was lowered by L-NAME but this did not reach significance. 5 Degranulation of mast cells, achieved by pretreatment with compound 48/80 (5 mg kg−1) for 3 consecutive days, significantly inhibited the oedema responses to only high dose SP (1 nmol) and [Sar9]SP sulphone (0.002 nmol). SP (0.2 nmol), septide (0.002 nmol), NKA (0.2 nmol) and NKB (0.3 nmol) were unaffected by this treatment. 6 RP 67, 580 (0.3-3 μmol kg−1) inhibited oedema induced by both 0.002 nmol and 0.1 nmol of septide. When using equiactive doses of SP only the response to the lower dose of 0.2 nmol SP was significantly inhibited, while RP 67, 580 (3 1μmol kg−1) did not affect the response to 1 nmol SP. 7 These results suggest distinct mechanisms of action for SP and septide in producing plasma protein extravasation in rat skin. The response induced by septide is blocked by RP 67, 580 and is both NO-dependent and mast-cell independent. In contrast the response to SP is only partially blocked by RP 67, 580 and is NO-independent. These data support the existence of a distinct ‘septide-sensitive’ receptor/ binding site and suggest that this site is involved in tachykinin-induced oedema formation in rat skin." @default.
• W2074027610 created "2016-06-24" @default.
• W2074027610 creator A5010124185 @default.
• W2074027610 creator A5020788754 @default.
• W2074027610 creator A5070551941 @default.
• W2074027610 date "1995-10-01" @default.
• W2074027610 modified "2023-10-03" @default.
• W2074027610 title "Demonstration of a ‘septide-sensitive’ inflammatory response in rat skin" @default.
• W2074027610 cites W1963944207 @default.
• W2074027610 cites W1967054403 @default.
• W2074027610 cites W1974775584 @default.
• W2074027610 cites W1981312249 @default.
• W2074027610 cites W1995901467 @default.
• W2074027610 cites W2007218604 @default.
• W2074027610 cites W2009936187 @default.
• W2074027610 cites W2013394559 @default.
• W2074027610 cites W2037067579 @default.
• W2074027610 cites W2068591703 @default.
• W2074027610 cites W2069269453 @default.
• W2074027610 cites W2072881186 @default.
• W2074027610 cites W2083565776 @default.
• W2074027610 cites W2084164533 @default.
• W2074027610 cites W2085291246 @default.
• W2074027610 cites W2087317810 @default.
• W2074027610 cites W2089266124 @default.
• W2074027610 cites W2089414938 @default.
• W2074027610 cites W2090431966 @default.
• W2074027610 cites W2092763906 @default.
• W2074027610 cites W2137810398 @default.
• W2074027610 cites W2144744298 @default.
• W2074027610 cites W2146390263 @default.
• W2074027610 cites W2162868406 @default.
• W2074027610 cites W2176147791 @default.
• W2074027610 cites W2409331219 @default.
• W2074027610 cites W2419411750 @default.
• W2074027610 doi "https://doi.org/10.1111/j.1476-5381.1995.tb15050.x" @default.
• W2074027610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1908977" @default.
• W2074027610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8564245" @default.
• W2074027610 hasPublicationYear "1995" @default.
• W2074027610 type Work @default.
• W2074027610 sameAs 2074027610 @default.
• W2074027610 citedByCount "12" @default.
• W2074027610 crossrefType "journal-article" @default.
• W2074027610 hasAuthorship W2074027610A5010124185 @default.
• W2074027610 hasAuthorship W2074027610A5020788754 @default.
• W2074027610 hasAuthorship W2074027610A5070551941 @default.
• W2074027610 hasBestOaLocation W20740276102 @default.
• W2074027610 hasConcept C118303440 @default.
• W2074027610 hasConcept C126322002 @default.
• W2074027610 hasConcept C134018914 @default.
• W2074027610 hasConcept C170493617 @default.
• W2074027610 hasConcept C185592680 @default.
• W2074027610 hasConcept C202871150 @default.
• W2074027610 hasConcept C203014093 @default.
• W2074027610 hasConcept C2776089194 @default.
• W2074027610 hasConcept C2776533618 @default.
• W2074027610 hasConcept C2776885963 @default.
• W2074027610 hasConcept C2777056410 @default.
• W2074027610 hasConcept C2778122271 @default.
• W2074027610 hasConcept C2778938600 @default.
• W2074027610 hasConcept C2779540182 @default.
• W2074027610 hasConcept C2781359426 @default.
• W2074027610 hasConcept C55938493 @default.
• W2074027610 hasConcept C71924100 @default.
• W2074027610 hasConcept C86803240 @default.
• W2074027610 hasConceptScore W2074027610C118303440 @default.
• W2074027610 hasConceptScore W2074027610C126322002 @default.
• W2074027610 hasConceptScore W2074027610C134018914 @default.
• W2074027610 hasConceptScore W2074027610C170493617 @default.
• W2074027610 hasConceptScore W2074027610C185592680 @default.
• W2074027610 hasConceptScore W2074027610C202871150 @default.
• W2074027610 hasConceptScore W2074027610C203014093 @default.
• W2074027610 hasConceptScore W2074027610C2776089194 @default.
• W2074027610 hasConceptScore W2074027610C2776533618 @default.
• W2074027610 hasConceptScore W2074027610C2776885963 @default.
• W2074027610 hasConceptScore W2074027610C2777056410 @default.
• W2074027610 hasConceptScore W2074027610C2778122271 @default.
• W2074027610 hasConceptScore W2074027610C2778938600 @default.
• W2074027610 hasConceptScore W2074027610C2779540182 @default.
• W2074027610 hasConceptScore W2074027610C2781359426 @default.
• W2074027610 hasConceptScore W2074027610C55938493 @default.
• W2074027610 hasConceptScore W2074027610C71924100 @default.
• W2074027610 hasConceptScore W2074027610C86803240 @default.
• W2074027610 hasIssue "4" @default.
• W2074027610 hasLocation W20740276101 @default.
• W2074027610 hasLocation W20740276102 @default.
• W2074027610 hasLocation W20740276103 @default.
• W2074027610 hasLocation W20740276104 @default.
• W2074027610 hasOpenAccess W2074027610 @default.
• W2074027610 hasPrimaryLocation W20740276101 @default.
• W2074027610 hasRelatedWork W1973462936 @default.
• W2074027610 hasRelatedWork W2023800668 @default.
• W2074027610 hasRelatedWork W2056069994 @default.
• W2074027610 hasRelatedWork W2066976641 @default.
• W2074027610 hasRelatedWork W2070599511 @default.
• W2074027610 hasRelatedWork W2074027610 @default.
• W2074027610 hasRelatedWork W2080226245 @default.
• W2074027610 hasRelatedWork W2124723195 @default.

• next